TITLE:
Observations from the Working Group Peritoneal Carcinosis
AUTHORS:
Manju Domnick, Martin Domnick, Iris Ernst, Frank P. Müller, Viktor Rempel, Norman Bitterlich, Hüseyin Sahinbas, Stefan Könemann, Stathis Philippou
KEYWORDS:
Multimodal and Complementary Therapy, Peritoneal Carcinosis, Quality of Life
JOURNAL NAME:
Journal of Cancer Therapy,
Vol.13 No.8,
August
11,
2022
ABSTRACT: The aim of this report was to
describe the feasibility, overall survival and quality of life of combining
multimodal therapy with a complementary therapy concept called LOTUS Care Cure program. The peritoneal
carcinomatosis (PC) working group described
their observations on the combination of multimodal therapy with a
complementary therapy concept based on 132 patients with different cancer
entities with suspected PC. PC was not confirmed by laparoscopy in 32.5% of the
patients included in the working group of patients with suspected PC. Patient compliance
and the feasibility were high. For Ki67, there is a cut-off at 45% with a
slower progression at 45%. The higher the Karnofsky index, the more improved the therapy and
tolerability, with a cut-off of 80%. Overall, 72.0% of patients died. The
median survival time in the overall population was 3.74 years (95% CI, 2.57 to
4.91) with a sharp decline in
the first 16 weeks. The quality of life of patients can be improved
with the implementation of the complementary LOTUS Care Cure Project. Overall,
the therapy of PC requires a multi-professional team of therapists and a
multimodal therapy concept. The multimodal concept together with the Lotus Care
Cure project shows very good feasibility with high compliance and ultimately
leads to better and low-risk patient care.